Search Immortality Topics:

Page 10«..9101112..2030..»


Coronavirus threat to global Nanotechnology in Medical Equipment Market : Analysis and In-depth Study on Nanotechnology in Medical Equipment Market…

Posted: May 27, 2020 at 12:42 pm

The report on the Nanotechnology in Medical Equipment market provides a birds eye view of the current proceeding within the Nanotechnology in Medical Equipment market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Nanotechnology in Medical Equipment market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Nanotechnology in Medical Equipment market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.

The Nanotechnology in Medical Equipment market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the Nanotechnology in Medical Equipment market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2657645&source=atm

The major players profiled in this Nanotechnology in Medical Equipment market report include:

The key players covered in this studyStryker Corporation3MAbbottThermo Fisher ScientificPerkinElmer, Inc.Starkey Hearing TechnologiesSmith + NephewDentsply InternationalMitsui Chemicals, Inc.AAP Implantate AG

Market segment by Type, the product can be split intoActive Implantable Medical EquipmentsBiochipPortable MaterialMarket segment by Application, split intoTreatment UsingDiagnostic UsingResearch Using

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Nanotechnology in Medical Equipment status, future forecast, growth opportunity, key market and key players.To present the Nanotechnology in Medical Equipment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nanotechnology in Medical Equipment are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2657645&licType=S&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2657645&source=atm

See more here:
Coronavirus threat to global Nanotechnology in Medical Equipment Market : Analysis and In-depth Study on Nanotechnology in Medical Equipment Market...

Recommendation and review posted by G. Smith

Nanotechnology in Cancer Treatment Market 2020 Industry Size, Growth, Share, Trends, Companies, Comprehensive Research and Forecast to 2026 – Cole of…

Posted: May 27, 2020 at 12:42 pm

Global Nanotechnology in Cancer Treatment Market Research Report 2020 provides the market size information, in-depth analysis along with competitive insights and segmentation. Additionally, this Report explorers Nanotechnology in Cancer Treatment market size, trends, share, growth, development plans, Investment Plan, cost structure and drivers analysis.

Get Sample Copy of this Report at https://www.orianresearch.com/request-sample/1599992

This report contains the major manufacturers analysis of the global Nanotechnology in Cancer Treatment industry. By understanding the operations of these manufacturers (sales volume, revenue, sales price and gross margin from 2015 to 2020), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.

Key STRATEGIC MANUFACTURERS include in this report:-

Abbott Laboratories

Combimatrix Corporation

GE Healthcare

Sigma-Tau Pharmaceuticals Inc.

Johnson & Johnson

Mallinckrodt Plc

Merck & Company Inc.

Nanosphere Inc.

Pfizer, Inc.

Celgene Corporation

Development policies and plans are discussed as well as growth rate, manufacturing processes, economic growth and worldwide strategies are analyzed. This Nanotechnology in Cancer Treatment Research Report also states import/export data, industry supply and consumption figures as well as cost structure, price, industry revenue and gross margin by regions.

This report studies the Nanotechnology in Cancer Treatment market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Nanotechnology in Cancer Treatment industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Nanotechnology in Cancer Treatment industry.

Global Nanotechnology in Cancer Treatment market: types and end industries analysis

The research report includes specific segments such as end industries and product types of Nanotechnology in Cancer Treatment. The report provides market size (sales volume and revenue) for each type and end industry from 2015 to 2020. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global Nanotechnology in Cancer Treatment market: regional analysis

Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Nanotechnology in Cancer Treatment in these countries from 2015 to 2020, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.

Market segment by Type, the product can be split into Nanoparticles Nanorods Nanofibers Graphene Metal-Organic Frameworks Nanobiosensors Nanofluidic Devices Nanotools Market segment by Application, split into Cancer Detection Imaging Drug Delivery Radiotherapy Immunotherapy Phototherapy

Order a Copy of Global Nanotechnology in Cancer Treatment Market Report @ https://www.orianresearch.com/checkout/1599992

Finally, the Report provides detailed profile and data information analysis of leading companies.

Major Points from Table of Contents-

1 Industry Overview of Nanotechnology in Cancer Treatment

2 Major Manufacturers Analysis of Nanotechnology in Cancer Treatment Industry

3 Global Nanotechnology in Cancer Treatment Market Analysis by Regions, Manufacturers, Types and End Users

4 North America Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

5 Europe Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

6 Asia Pacific Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

7 Latin America Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

8 Middle East & Africa Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

9 Marketing Channel, Distributors and Traders Analysis

10 Global Nanotechnology in Cancer Treatment Market Forecast by Regions, Countries, Manufacturers, Types and End Users

11 Industry Chain Analysis of Nanotechnology in Cancer Treatment

12 Nanotechnology in Cancer Treatment New Project Investment Feasibility Analysis

13 Nanotechnology in Cancer Treatment Research Findings and Conclusion

14 Appendix

Note: We can also customize this record and provide individual chapters or a region-wise breakdown record such as North America, Europe or Asia. Also, if you have any special requirements, please let us know and we will offer you the record as you want.

About Us:

Orian Research is one of the most comprehensive collections of market intelligence records on the World Wide Web. Our records repository boasts of over 500000+ industry and country research from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:-

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Go here to see the original:
Nanotechnology in Cancer Treatment Market 2020 Industry Size, Growth, Share, Trends, Companies, Comprehensive Research and Forecast to 2026 - Cole of...

Recommendation and review posted by G. Smith

Study Shows Protons Tend to Move Along Interface Between Two Mediums – AZoM

Posted: May 27, 2020 at 12:42 pm

Written by AZoMMay 26 2020

The H+ proton contains a single ion of hydrogen, which is the lightest and smallest among all the chemical elements. Such protons occur in water naturally where a small proportion of H2O molecules gets split up instantaneously.

Image Credit: Ecole Polytechnique Federale de Lausanne (EPFL)

The amount of protons in a liquid decides if the solution is basic or acidic. Moreover, the protons are highly mobile, shifting via water by jumping from one water molecule to another.

There has been a good understanding of the way this transport process functions in a body of water. However, the existence of a solid surface can drastically impact the behavior of protons, and at present, the researchers have very few tools to quantify such movements at water-solid interfaces.

In the latest study, Jean Comtet, a postdoctoral researcher at Ecole Polytechnique Federale de Lausanne (EPFL) School of Engineering (STI), has offered the first-ever insight into the behavior of protons when water comes into contact with a solid surface, diving down to the maximum scale of a single proton and single charge.

The study results were published in the Nature Nanotechnology journal and show that protons move along the interface between these two mediums. Scientists from the Department of Chemistry at the cole Normale Suprieure (ENS) in Paris also contributed to the study by performing simulations.

Comtet examined the interface between a boron nitride crystal (a very smooth material) and water.

The surface of the crystal can contain defects. We found that these imperfections act as markers, reemitting light when a proton binds to them.

Jean Comtet, Postdoctoral Researcher, School of Engineering, Ecole Polytechnique Federale de Lausanne

Comtet used a super-resolution microscope to view such fluorescence signals and quantify the location of the defects to within about 10 nma very high degree of accuracy. The more fascinating fact of the study is that it still offered a new understanding of how the crystalline defects are triggered.

We observed defects on the surface of the crystal lighting up one after another when they came into contact with water. We realized that this lighting pattern was produced by a single proton jumping from defect to defect, generating an identifiable pathway.

Jean Comtet, Postdoctoral Researcher, School of Engineering, Ecole Polytechnique Federale de Lausanne

One of the main findings of the study was that the protons move along the water-solid interface. According to Comtet, The protons keep on moving, but hugging the surface of the solid. Thats why we see these kinds of patterns.

Aleksandra Radenovic, professor at EPFLs Laboratory of Nanoscale Biology (LBEN), stated that This is a major experimental breakthrough that furthers our understanding of how charges in water interact with solid surfaces.

Our observations, in this specific context, can easily be extrapolated to other materials and environments. These discoveries could have important implications in many other fields and disciplines, from understanding biological processes at the cell-membrane interface to designing more efficient filters and batteries.

Jean Comtet, Postdoctoral Researcher, School of Engineering, Ecole Polytechnique Federale de Lausanne

Comtet, J., et al. (2020) Direct observation of water-mediated single-proton transport between hBN surface defects. Nature Nanotechnology. doi.org/10.1038/s41565-020-0695-4.

Source: https://www.epfl.ch/en/

Read the original:
Study Shows Protons Tend to Move Along Interface Between Two Mediums - AZoM

Recommendation and review posted by G. Smith

New 5G Switches Mean Battery Life Improvements, Higher Bandwidth and Speeds – UT News | The University of Texas at Austin

Posted: May 27, 2020 at 12:42 pm

AUSTIN, Texas The 5G revolution has begun, and the first lines of phones that can access the next generation of wireless speeds have already hit the shelves. Researchers at The University of Texas at Austin and the University of Lille in France have built a new component that will more efficiently allow access to the highest 5G frequencies in a way that increases devices battery life and speeds up how quickly we can do things like stream high-definition media.

Smartphones are loaded with switches that perform a number of duties. One major task is jumping between networks and spectrum frequencies: 4G, Wi-Fi, LTE, Bluetooth, etc. The current radio-frequency (RF) switches that perform this task are always running, consuming precious processing power and battery life.

The switch we have developed is more than 50 times more energy efficient compared to what is used today, said Deji Akinwande, a professor in the Cockrell School of Engineerings Department of Electrical and Computer Engineering who led the research. It can transmit an HDTV stream at a 100 gigahertz frequency, and that is unheard of in broadband switch technology.

Akinwande and his research team published their findings today in the journal Nature Electronics.

It has become clear that the existing switches consume significant amounts of power, Akinwande said. And that power consumed is useless power.

The new switches stay off, saving battery life for other processes, unless they are actively helping a device jump between networks. They have also shown the ability to transmit data well above the baseline for 5G-level speeds.

The U.S. Defense Advanced Research Projects Agency (DARPA) has for years pushed for the development of near-zero-power RF switches. Prior researchers have found success on the low end of the 5G spectrum where speeds are slower but data can travel longer distances. But, this is the first switch that can function across the spectrum from the low-end gigahertz (GHz) frequencies to high-end terahertz (THz) frequencies that could someday be key to the development of 6G.

The UT teams switches use the nanomaterial hexagonal boron nitrite (hBN). It is an emerging nanomaterial from the same family as graphene, the so-called wonder material. The structure of the switch involves a single layer of boron and nitrogen atoms in a honeycomb pattern, which Akinwande said is almost 1 million times thinner than human hair, sandwiched between a pair of gold electrodes.

The impact of these switches extends beyond smartphones. Satellite systems, smart radios, reconfigurable communications, the internet of things and defense technology are all examples of other potential uses for the switches.

Radio-frequency switches are pervasive in military communication, connectivity and radar systems, said Dr. Pani Varanasi, division chief of the materials science program at the Army Research Office, an element of the U.S. Army Combat Capabilities Development Commands Army Research Laboratory that helped fund the project. These new switches could provide large performance advantage compared to existing components and can enable longer battery life for mobile communication, and advanced reconfigurable systems.

This research spun out of a previous project that created the thinnest memory device ever producedalso using hBN. Akinwande said sponsors encouraged the researchers to find other uses for the material, and that led them to pivot to RF switches.

The UT team includes electrical and computer engineering professor Jack Lee and graduate students Myungsoo Kim, Ruijing Ge and Xiaohan Wu. They worked with researchers at the University of Lilles Institute of Electronics, Microelectronics and Nanotechnology, led by Emiliano Pallecchi and Henri Happy.

The research was funded through grants from the U.S. Office of Naval Research, the Army Research Office, and an Engineering Research Center funded by the National Science Foundation. Fabrication of the switch was partly done at the Texas Nanofabrication Facility, and hBN samples were provided by Grolltex Inc.

Read this article:
New 5G Switches Mean Battery Life Improvements, Higher Bandwidth and Speeds - UT News | The University of Texas at Austin

Recommendation and review posted by G. Smith

Precision Mobile Testing Is Key to Opening the Economy Safely – Scientific American

Posted: May 27, 2020 at 12:42 pm

We are fighting an unconventional, asymmetric world war against an invisible enemya war which could continue for another 18 months. COVID-19, like the 1918 influenza pandemic, could have multiple phases of resurgence. Great American wars have been won through technological innovation. America can and will win this war on COVID-19, and against future pandemics and biowarfare attacks, by upgrading its national security and health care infrastructure, which has not changed much in almost 40 years.

The COVID-19 pandemic has exposed critical gaps in our current testing infrastructure. With currently available testing technologies, less than 5 percent of Americans have been tested so far. But to reopen the U.S. economy and rehabilitate industries, we will need widespread community-based precision testing of hundreds of millions of people. We will need to establish COVID-free safe zones for work and travel. This means people will need to be tested repeatedly with high-precision, mobile tests. To restore public confidence, the testing technology must be accurate and precise; this means that there should be no false negatives and no false positives.

Our current systems for diagnosing diseases like COVID-19 relies on a 400-year-old antiquated paradigm of centralized health care delivery, focusing primarily on testing sick patients at hospitals or clinics. In an age of cell phones and self-driving cars, we find ourselves fighting a global pandemic with inadequate armament and intelligence. This is much like fighting World War III with a musket.

NOT ALL TESTS ARE CREATED EQUAL

We are witnessing, almost daily, an increasing number of tests being added to our toolbox for detecting COVID-19. However, not all tests are created equal.

The most accurate testing for COVID-19 on the market today is enabled by molecular diagnostics, based on a 35-year-old technology called PCR (an acronym for polymerase chain reaction). By exponentially amplifying the SARS-CoV-2 viral RNA, this technology is typically capable of detecting the presence of even a small number of viruses in a sample with high sensitivity and specificity. The manufacturers of these PCR machines and reagents, as well as the centralized lab service companies, have made significant efforts to increase their throughput to provide hundreds of thousands more COVID-19 tests nationwide, but confined mostly to hospitals, labs and clinical settings. This centralized testing system requires large bulky machines and extensive overhead infrastructure, complex sample transport logistics, highly trained personnel, high volumes of expensive reagents and centralized lab facilities. This system does not lend itself to providing widespread and recurrent testing for hundreds of millions of people.

The holy grail of testing has long been touted to be point-of-care (POC) testing that bypasses the need of a centralized lab infrastructure and complex logistics. The most common POC testing currently available on the market today are serology tests or immunoassay tests that detect the presence of antibodies. These immunoassays could be used to map out individuals as they build up antibodies to the SARS-CoV-2 virus and to conduct further research to determine if people are gaining immunity after exposure and which antibodies, if any, may confer immunity to these patients.

These POC serological tests, despite being quick and cheap, are limited in their use as a screening test, because they intrinsically suffer from a high rate of false positives and false negatives and still require gold standard PCR confirmatory testing in centralized labs. Each individual returning to work or resuming travel with a "false negative" test becomes an unidentified walking bioweapon, who has the potential to infect thousands of others and induce millions of dollars of damage to our economy. Each person with a false positive screening test likewise creates panic and further burdens our already overwhelmed health care system.

Some of the large manufacturers of conventional PCR machines and reagents have made significant strides in introducing smaller and faster versions of their traditional PCR machines, reducing their size from 400 pounds to 640 pounds and hence bringing them closer to POC. This is a very good step in the right direction, but the ability to truly decentralize these machines outside of a lab or hospital setting will involve overcoming critical engineering barriers to achieve target performance metrics of accuracy, precision, speed, smaller sample sizes and user-friendliness. The quest to make these traditional molecular diagnostics systems smaller and faster is intrinsically limited by a glass ceiling of fundamental constraints imposed by physics and engineering.

NANOBIOPHYSICS REWRITES RULES

As a physicist and physician, I have spent the past few decades developing breakthrough technologies at the nexus of physics, biomedicine, and nanotechnology. With the help of awards from agencies like DARPA, DOD, DOE, NSF, my research lab at the Nanobiosym Research Institute has demonstrated advanced capabilities to control molecular reactions at the nanoscale, thereby enabling faster and smaller, IOT-connected, precision-engineered diagnostic devices like ourX Prizewinning Gene-RADAR technology.

We harness the latest tools of physics and nanotechnology to enable faster, smaller, higher precision testing, unlike traditional molecular testing approaches that rely primarily on tools from chemistry and molecular biology. The science of nanobiophysics provides a quantum leap in testing capabilities, enabling increased mobility with real-time results while maintaining gold standard performance, but without the infrastructure, logistics and overhead requirements of traditional centralized labs.

Even as we continue to unlock the full power of the new science of nanobiophysics, we should immediately start building a new generation of technological infrastructure in our nation. This will help reopen our economy and get Americans safely back to work, across all industries, without endangering public health and safety. This will restore travel and trade by rehabilitating ailing industries including airlines, retail and hospitality. Anybody who wants a test should be able to easily get one.

Our nation's highly developed but centralized testing infrastructure has simply not been set up to provide decentralized precision testing on a mass scale, as Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases,acknowledgedin a White House press conference. Our current system focuses chiefly on testing sick people in a clinic or hospital only after they show symptoms, and is based on an outdated paradigm of centralized health care delivery that was developed in the industrial revolution. As such, it is grossly inadequate to protect us from COVID-19 and future pandemics and biowarfare attacks.

The longstanding inertia and barriers to entry in our health care system have delayed adoption of the latest diagnostic technologies, despite them being ready to scale. As a result, this comprehensive nanoscale precision testing is simply not yet available to our citizens. It took a Manhattan Project to bring the latest atomic physics technology to scale to win World War II. Today, we need a similar effort to scale up our latest advances in nanobiophysics technology to fight and win this World War III. History will show that this critical leap forward was the step that saved the economy and culture, and restored faith in the safety of our great nation.

Read more about the coronavirus outbreak from Scientific American here, and read coverage from our international network of magazines here.

More:
Precision Mobile Testing Is Key to Opening the Economy Safely - Scientific American

Recommendation and review posted by G. Smith

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascula | IJN – Dove Medical Press

Posted: May 27, 2020 at 12:42 pm

Rajasekharreddy Pala,1,2 VT Anju,3 Madhu Dyavaiah,3 Siddhardha Busi,4 Surya M Nauli1,2

1Department of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618, USA; 2Department of Medicine, University of California Irvine, Irvine, CA 92868, USA; 3Department of Biochemistry and Molecular Biology, School of Life Sciences, Pondicherry University, Puducherry, India; 4Department of Microbiology, School of Life Sciences, Pondicherry University, Puducherry, India

Correspondence: Rajasekharreddy Pala; Surya M Nauli Tel +714-516-5462; +714-516-5480Fax +714-516-5481Email rrpala@chapman.edu; nauli@chapman.edu

Abstract: Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are not very useful, which demands promising alternative methods. Nanoscience and nanotechnology open a new window in the area of CVDs with an opportunity to achieve effective treatment, better prognosis, and less adverse effects on non-target tissues. The application of nanoparticles and nanocarriers in the area of cardiology has gathered much attention due to the properties such as passive and active targeting to the cardiac tissues, improved target specificity, and sensitivity. It has reported that more than 50% of CVDs can be treated effectively through the use of nanotechnology. The main goal of this review is to explore the recent advancements in nanoparticle-based cardiovascular drug carriers. This review also summarizes the difficulties associated with the conventional treatment modalities in comparison to the nanomedicine for CVDs.

Keywords: cardiovascular diseases, nanoscience, nanoparticles, nanomedicine, nanocarriers, treatment

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Visit link:
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascula | IJN - Dove Medical Press

Recommendation and review posted by G. Smith


Page 10«..9101112..2030..»